Signal strength of ADE at the drug level ranked by reports. حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

Outcomes distribution of drug patients with the top 50 positive signal frequency by 4 methods (ROR PRR IC MGPS). حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

Time-to-onset analysis using the Weibull distribution test. حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

Characteristics of AEs reports. حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

Top 50 drugs sorted by frequency of positive signals stratified by reporter – by 4 methods (ROR PRR IC MGPS). حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

Gender Difference analysis of the top 50 drugs ranked by frequency by four methods (ROR PRR IC MGPS). حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

Top 50 Drugs with positive signals by frequency – by four methods (ROR PRR IC MGPS). حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

Two-by-two contingency table for disproportionality analysis. حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

The top 50 drugs by frequency of positive signals stratified by sex – by 4 methods (ROR PRR IC MGPS). حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

Flowchart. حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

The top 25 drugs sorted by frequency of positive signals stratified by age – by 4 methods (ROR PRR IC MGPS). حسب Jun Hua Lai (22676523)

مؤلفون آخرون:

The principles of disproportionate measurement and the criteria for signal detection. حسب Jun Hua Lai (22676523)

مؤلفون آخرون: